Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System

A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00726128

Acronym

VueLock

Enrollment

371

Registered

2008-07-31

Start date

1998-08-31

Completion date

2009-09-30

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Disc Disease, Pseudarthrosis, Scoliosis, Trauma, Tumor

Keywords

Degenerative Disc disease (DDD)

Brief summary

To prospectively collect radiographic and outcome data on patients who are having cervical spine fusion surgery with the VueLock™ Anterior Cervical Plate System

Detailed description

The purpose is to prospectively collect radiographic and outcome data on patients who are having cervical spine fusion surgery with the VueLock™ Anterior Cervical Plate System.

Interventions

DEVICEVueLock™ Anterior Cervical Plate

Implanted in subjects having an ACDF (Anterior cervical discectomy and fusion)

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. The patient will undergo anterior cervical fusion with the VueLock™ Anterior Cervical Plate System for treatment of degenerative disc disease (as defined by neck pain of discogenic origin of the disc confirmed by patient history and radiographic studies), trauma, tumors, deformity (defined as kyphosis, lordosis, or scoliosis), pseudarthrosis, and/or failed previous fusion. 2. The patient must be available for follow-up during the study. 3. The patient must be skeletally mature (epiphyses closed).

Exclusion criteria

1. Patients with other pathology at the involved spinal level, e.g., osteomyelitis, Paget's disease, pathologic fracture, etc. 2. Patients with a disease entity or condition that totally precludes the possibility of bony fusion such as known active cancer, etc. 3. Pregnant or nursing females. 4. Patients who in the opinion of the investigator would be psychologically unwilling or unable to understand or complete the protocol, especially those unwilling or unstable to participate in the follow-up.

Design outcomes

Primary

Measure	Time frame
Proportion of Patients with radiographic fusion	24 Months

Secondary

Measure	Time frame
Neck Disability Index and Short Form Health Survey (SF-36) scores, change from baseline	24 Month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026